Estimates Revisions Mesoblast Limited OTC Markets
Stocks
MEOBF
AU000000MSB8
Biotechnology & Medical Research
|
Delayed
OTC Markets
16:30:06 26/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 1.900 USD | +15.15% |
|
+0.53% | - |
| 10:57am | Mesoblast Fiscal 2026 Loss Narrows, Revenue Rises | MT |
| 08:20am | Mesoblast Limited, 2026 Earnings Call, Aug 26, 2026 |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- MSB Stock
- MEOBF Stock
- Consensus Mesoblast Limited
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
